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The importance of bovine tuberculosis to the economy and public health is being assessed in Ethiopia to generate the 
evidence base for better control options. A cross sectional prevalence survey in cattle and human populations will be 
conducted. The influence of cattle genetic background on susceptibility to bovine TB will be studied. Prevalence and 
type of M. bovis in exotic and local breeds will be compared and the immunology, pathology and genetics of cattle 
susceptibility studied. The efficacy of neonatal BCG vaccination will be tested in a natural transmission setting and a 
protocol developed for such trials. The cost of bovine TB to the society will be estimated and a cost-benefit model of 
intervention developed. The project will strengthen local capacity to undertake mycobacterial typing and 
epidemiological modelling studies.  [Ethiop.J.Health Dev. 2008;22(Special Issue):128-131] 
 
Introduction 
As part of its poverty reduction strategy, Ethiopia has 
recently embarked on a programme of increasing milk 
production through intensive breeding of exotic dairy 
cattle. Holstein-Friesians have been imported and 
distributed to farmers in many regions, including the 
Sellale and Holeta areas near Addis Ababa. Holstein-
Friesian cows yield up to 5-7 times more milk per kg body 
weight than local Zebu breeds of Bos indicus ancestry (1). 
There is much evidence however that exotic breeds are 
more susceptible to bovine TB than local Zebu. The 
programme to increase milk may therefore have the 
inadvertent effect of increasing bovine TB. 
 
Bovine tuberculosis is an important cause of economic 
loss in affected communities. It reduces milk yield and 
meat production in infected animals.  M. bovis may be 
transmitted through aerosols, or through the consumption 
of raw milk or other contaminated products posing a 
serious threat to human health.   
 
Bovine tuberculosis has been eradicated from most of the 
developed world through the test and slaughter strategy 
where infected animals are removed. The UK spends 
about 100 million pounds sterling every year 
implementing these measures (2). The high cost of the test 
and slaughter policy restricts its application for the control 
of bovine TB in developing countries.  In addition, 
available resources are often directed at combating human 
TB caused by M. tuberculosis.  
 
Ethiopia ranks 8th in the number of newly diagnosed TB 
cases globally (3).  This is further aggravated by the 
spreading HIV epidemic. There is however little 
information on the contribution of M. bovis to this burden. 
The proportion of extra-pulmonary TB has been rising 
steadily over the last decade, currently accounting for 35% 
of all newly diagnosed cases (4). For comparison, the rates 
for Uganda and Kenya are 8% and 14% respectively (3). 
Over three-quarters of the extra-pulmonary cases affect 
lymph nodes, raising the possibility of orally acquired M. 
bovis. 
 
A consortium involving researchers from Imperial College 
London, the Veterinary Laboratories Agency, Weybridge 
(UK), Trinity College Dublin (Ireland), Swiss Tropical 
Institute, Basel (Switzerland), International Livestock 
Research Institute, Nairobi (Kenya) and the Armauer 
Hansen Research Institute in Addis Ababa was established 
to study the problem of bovine TB in Ethiopia. The project 
was designed to measure the cost of bovine TB to Ethiopia 
by assessing its impact on livestock and human health. 
Based on the findings, an economic model will be 
developed to assess the likely effect of introducing 
Holstein cattle into the local herd and of implementing 
control measures for TB. Three questions are being 
addressed by the study: the magnitude and economic cost 
of the bovine TB problem in Ethiopia, the likely impact 
and economic cost of changes in the genetic background 
of the Ethiopian cattle herd, and cost-effective 
interventions to reduce the impact of bovine TB in 
Ethiopia. 
 
Methods and expected outcomes 
The project is funded by the Wellcome Trust as part of the 
Animal Health in the Developing World initiative and 
received approval from institutional ethical review 
committees and the National Ethical Review Committee 
of Ethiopia. In addition, an independent committee 
composed of veterinarians reviewed and approved the 
veterinary aspects of the proposal. The study is currently 
being undertaken in seven linked work packages (WP) that 
complement each other.  
 
WP 1 - Cross-sectional survey of M. bovis in Ethiopian 
cattle (Stephen Gordon, Endalamaw Gadisa, Stefan 
Berg). 
The objective of this WP is to obtain an overview of the 
population structure of M. bovis in Ethiopia and to 
determine which strains show a greater prevalence, and 
whether particular strains show association with certain 
cattle breeds. Samples are collected from suspected TB 
lesions during routine examination of cattle slaughtered in 
the abattoirs of Gondar, Woldeya, Ghimbi, Jinka and 
Butajira and cultured for mycobacteria in Addis Ababa. 
The isolates are characterized using molecular techniques, 
initially with spoligotyping and VNTR and subsequently 
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with multi-locus sequence typing (MLST) and whole 
genome microarray analysis for selected isolates. Findings 
will be compared with results from other settings such as 
the UK where a control policy has been in place for over 
50 years. 
 
WP2: Cross-sectional survey of M. bovis in human 
lymph node TB (Abraham Aseffa, Howard Engers).  
Fine needle aspirate (FNA) material has recently been 
shown to be adequate for the diagnosis of TB with 
cytology, culture or polymerase chain-reaction (PCR), 
circumventing the need for the more invasive excision 
biopsy.  In this WP, mycobacterial isolates from  a total of 
1300 FNA samples collected from patients with suspected 
TB lymphadenitis presenting at the hospitals in Gondar, 
Woldeya, Ghimbi, Jinka and Butajira are cultured and 
isolates characterized.  The study will identify the 
proportion of M. bovis in cultures in FNA samples from 
cervical lymph nodes of patients with suspected TB 
lymphadenitis and will characterize the genetic diversity 
of M. bovis isolates from humans and compare these with 
isolates from cattle to establish a zoonotic link. The data 
will be linked to the epidemiological analysis in WP6. 
Data from patients consenting to be tested for HIV will be 
used to assess the influence of HIV on the risk of TB 
lymphadenitis. In this WP, the sensitivity of PCR in the 
diagnosis of TB lymphadenitis from FNA samples will be 
determined using culture as gold standard. 
 
WP3 - Prevalence study of bovine TB in Sellale region 
(Gobena Ameni, Martin Vordermeier): In this WP, the 
prevalence of bovine TB in the different breeds of cattle 
kept on pasture in Sellale was determined (5). Single 
intradermal comparative tuberculin skin testing was 
performed on 925 Holstein cattle, 2578 Zebu breeds and 
1921 crossbreeds. The prevalence of bovine TB in Zebu 
was 11.6% compared to 11.9% in cross breeds and 22.2% 
among Holstein cattle. Overall prevalence was 13.5%.  
The risk of bovine TB among Holstein cattle was found to 
be at least two times higher than among the Zebu kept on 
pasture, under identical filed husbandry management.  The 
sensitivity of the INF-  γ test using avian and bovine 
PPD, ESAT-6 and CFP-10 peptide cocktails as well as 
serological assays in comparison to the conventional 
tuberculin skin test was evaluated (6). A significantly 
higher IFN- γ response to the cocktail was observed 
among Holsteins compared to the Zebu, and among 
Holsteins kept indoors than Holstein cattle kept in a 
pasture. A higher lesion severity was also noted in 
Holstein cattle kept indoors compared to those kept in 
pasture. Cattle husbandry was thus found to be a 
predominant factor affecting the pathology of bovine TB 




WP4 - An analysis of the influence of cattle genetic 
background on susceptibility to bovine TB (Dan 
Bradley, Yonas Hirutu): Although there is evidence that 
Bos indicus cattle are more resistant to bovine TB than Bos 
taurus, a direct link between cattle susceptibility to M. 
bovis and genetic admixture component is yet to be 
established.  Comprehensive individual admixture 
estimates will be analysed against epidemiological, 
susceptibility and       M. bovis strain types to detect any 
significant differences between the two cattle lineages. A 
heritable component of susceptibility will be highlighted. 
Several candidate genes implicated in susceptibility to M. 
tuberculosis may play a similar role in M. bovis infection. 
Genetic variants unique to one or other bovine lineage will 
be ascertained using single nucleotide polymorphisms 
(SNPs). Physically linked clusters of tightly linked Bos 
Taurus/Bos indicus diagnostic SNP markers, selected 
from mapped data from the bovine genome project, will 
be used to assess the amount of recombination that has 
occurred between ancestral genomes to capture relative 
contribution of African and European components within 
the Bos taurus fraction of the genome.  A set of 
informative SNP markers for tracking admixture in 
African cattle will thus be developed. Admixture will be 
estimated for the infected samples from the prevalence 
studies. The study is expected to provide information on 
the genetic basis for differences in susceptibility to bovine 
TB between the two cattle lineages and provide data on 
involvement of candidate genes in disease susceptibility. 
 
WP5 - Experimental infection of cattle with M. bovis 
(Mboya Burudi, Richard Bishop): In this WP, a 
controlled experimental challenge model will be 
employed to generate comparative data on immune 
responses to BCG vaccination in Holstein and Bos indicus 
cattle and further define differences in genetic 
susceptibility between the two breeds. It will offer an 
experimental platform to support a genome-wide screen 
for loci that influence differential susceptibility to bovine 
TB. Groups of Holstein and Bos indicus cattle will be 
vaccinated with BCG or infected with the sequenced M. 
bovis field strain and their immune responses assessed 
regularly using various immunological assays including 
host gene arrays to study gene expression.  
 
WP6 - Estimation of the costs to society of bovine TB 
and cost-benefit model of interventions (Jakob 
Zinnstag, Rea Tschopp, Getu Melese). The effect of 
infection on livestock productivity, on human health and 
human-health related costs including income loss will be 
assessed to estimate the cost of bovine TB to the Ethiopian 
society. The prevalence of infection in cattle and humans, 
the risk factors for the transmission of M. bovis  in  cattle 
and to humans and the efficacy of various  
 
 
intervention strategies will be estimated to develop a 
mathematical transmission model for M. bovis in a similar 
way to that described for brucellosis by Zinnstag et al (7). 
Disease prevalence in cattle and humans will be estimated 
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based on the literature, abattoir survey data and data from 
human samples collected from cervical lymph nodes and 
pulmonary TB patients. Household surveys will be 
conducted on bovine TB cases and matched controls to 
determine risk factors. Analysis of the health benefits of 
intervention strategies will be computed in monetary terms 
for the agricultural (avoided losses) and public health 
sectors (avoided costs) as well as for the households of 
index cases (avoiding treatment cost, income loss, and 
coping cost). Cost-effectiveness of different intervention 
strategies will be assessed. Various alternatives exist for 
the control of bovine TB: different BCG vaccination 
scenarios, test and slaughter strategy and the 
pasteurization of milk. The transmission model for 
brucellosis will be modified and validated as far as 
possible from repeated cross sectional surveys. It is 
expected that an animal to human bovine TB transmission 
model linked to an economic assessment package capable 
of testing different control strategies will be generated.  
The study will provide information on the cost of bovine 
TB to human health and agricultural sectors.  At the end, 
the most profitable and effective strategies to control 
bovine TB in Ethiopia will be described. 
 
WP 7 - Evaluation of the impact of cattle vaccination 
on the development of bovine TB (Glyn Hewinson, 
Gobena Ameni):  Vaccination is an attractive control 
strategy for bovine TB. A realistic estimate of vaccine 
efficacy under conditions that reproduce the natural route 
and dose of infection encountered in the field is a 
requirement to develop a cost-benefit analysis. The 
efficacy of neonatal BCG vaccination will be assessed by 
monitoring disease in a cohort of vaccinated and control 
sentinel calves introduced into the naturally infected donor 
herd at the Holeta farm of the National Artificial 
Insemination Centre (NAIC), Ministry of Agriculture and 
Rural Development. The vaccine test is carried out in 
cattle managed under husbandry conditions similar to the 
normal farming situation where these segregated cattle are 
left to graze during the day and kept in cattle sheds 
overnight.  The study will determine the protective 
efficacy of neonatal BCG vaccination in Holstein cattle 
under intensive farming conditions in Ethiopia and 
establish a protocol for field evaluation of bovine TB 
vaccines in a natural transmission setting.  
 
Capacity building: A major outcome of this project is 
strengthening the research capacity at AHRI. Priority has 
been given to develop expertise in molecular typing and 
capacity to carry out epidemiology and modelling 
research. This consortium project has so far enrolled four 
PhD students (three of whom are Ethiopian) in a 
“sandwich” training scheme. A fifth PhD candidate with 
an MD background will be enrolled at Addis Ababa 
University (AAU) soon.  The AHRI TB laboratory has 
been upgraded with biosafety cabinets and a generator 
purchased for the partner laboratory at the Aklilu Lema 
Institute of Pathobiology, AAU. A small laboratory is 
being constructed at Holeta farm. The project has 
supported field practice and thesis writing for 15 final year 
DVM students so far. Training workshops have been 
conducted in Addis Ababa for veterinarians and medical 
professionals on epidemiology and genetics. 
 
The project has already succeeded in initiating 
communication between human and animal health 
workers in Ethiopia. It is hoped that the established 
capacity will strengthen further collaborative research on 
zoonotic diseases of public health and economic 
importance in the future. 
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